Logo image of IBM.DE

INTL BUSINESS MACHINES CORP (IBM.DE) Stock Fundamental Analysis

FRA:IBM - Deutsche Boerse Ag - US4592001014 - Common Stock - Currency: EUR

231.3  +0.2 (+0.09%)

Fundamental Rating

4

Taking everything into account, IBM scores 4 out of 10 in our fundamental rating. IBM was compared to 76 industry peers in the IT Services industry. IBM has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, IBM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IBM was profitable.
In the past year IBM had a positive cash flow from operations.
IBM had positive earnings in each of the past 5 years.
In the past 5 years IBM always reported a positive cash flow from operatings.
IBM.DE Yearly Net Income VS EBIT VS OCF VS FCFIBM.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

IBM has a Return On Assets (3.76%) which is in line with its industry peers.
IBM's Return On Equity of 20.36% is amongst the best of the industry. IBM outperforms 85.53% of its industry peers.
IBM's Return On Invested Capital of 7.22% is in line compared to the rest of the industry. IBM outperforms 44.74% of its industry peers.
IBM had an Average Return On Invested Capital over the past 3 years of 7.26%. This is below the industry average of 10.85%.
Industry RankSector Rank
ROA 3.76%
ROE 20.36%
ROIC 7.22%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
IBM.DE Yearly ROA, ROE, ROICIBM.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 8.71%, IBM belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
In the last couple of years the Profit Margin of IBM has declined.
With an excellent Operating Margin value of 14.89%, IBM belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
IBM's Operating Margin has improved in the last couple of years.
The Gross Margin of IBM (57.04%) is comparable to the rest of the industry.
IBM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.89%
PM (TTM) 8.71%
GM 57.04%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
IBM.DE Yearly Profit, Operating, Gross MarginsIBM.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBM is destroying value.
Compared to 1 year ago, IBM has more shares outstanding
Compared to 5 years ago, IBM has more shares outstanding
IBM has a better debt/assets ratio than last year.
IBM.DE Yearly Shares OutstandingIBM.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IBM.DE Yearly Total Debt VS Total AssetsIBM.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

IBM has an Altman-Z score of 3.33. This indicates that IBM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.33, IBM is in the better half of the industry, outperforming 71.05% of the companies in the same industry.
IBM has a debt to FCF ratio of 5.06. This is a neutral value as IBM would need 5.06 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.06, IBM is in line with its industry, outperforming 46.05% of the companies in the same industry.
A Debt/Equity ratio of 2.10 is on the high side and indicates that IBM has dependencies on debt financing.
IBM has a Debt to Equity ratio of 2.10. This is amonst the worse of the industry: IBM underperforms 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 5.06
Altman-Z 3.33
ROIC/WACC0.75
WACC9.67%
IBM.DE Yearly LT Debt VS Equity VS FCFIBM.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 1.01 indicates that IBM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.01, IBM is not doing good in the industry: 71.05% of the companies in the same industry are doing better.
A Quick Ratio of 0.97 indicates that IBM may have some problems paying its short term obligations.
The Quick ratio of IBM (0.97) is worse than 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.97
IBM.DE Yearly Current Assets VS Current LiabilitesIBM.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.22% over the past year.
The Earnings Per Share has been decreasing by -4.21% on average over the past years.
Looking at the last year, IBM shows a small growth in Revenue. The Revenue has grown by 1.23% in the last year.
The Revenue has been growing slightly by 1.69% on average over the past years.
EPS 1Y (TTM)3.22%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)1.23%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%0.55%

3.2 Future

Based on estimates for the next years, IBM will show a small growth in Earnings Per Share. The EPS will grow by 7.16% on average per year.
IBM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.68% yearly.
EPS Next Y6.87%
EPS Next 2Y6.4%
EPS Next 3Y6.27%
EPS Next 5Y7.16%
Revenue Next Year5.33%
Revenue Next 2Y4.83%
Revenue Next 3Y4.61%
Revenue Next 5Y4.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBM.DE Yearly Revenue VS EstimatesIBM.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20B 40B 60B 80B
IBM.DE Yearly EPS VS EstimatesIBM.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.61 indicates a quite expensive valuation of IBM.
Compared to the rest of the industry, the Price/Earnings ratio of IBM is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.35. IBM is around the same levels.
A Price/Forward Earnings ratio of 22.46 indicates a rather expensive valuation of IBM.
IBM's Price/Forward Earnings is on the same level as the industry average.
IBM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.20.
Industry RankSector Rank
PE 25.61
Fwd PE 22.46
IBM.DE Price Earnings VS Forward Price EarningsIBM.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

69.74% of the companies in the same industry are cheaper than IBM, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as IBM.
Industry RankSector Rank
P/FCF 19.53
EV/EBITDA 20.14
IBM.DE Per share dataIBM.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IBM does not grow enough to justify the current Price/Earnings ratio.
IBM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.73
PEG (5Y)N/A
EPS Next 2Y6.4%
EPS Next 3Y6.27%

4

5. Dividend

5.1 Amount

IBM has a Yearly Dividend Yield of 2.58%. Purely for dividend investing, there may be better candidates out there.
IBM's Dividend Yield is a higher than the industry average which is at 6.98.
IBM's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.58%

5.2 History

The dividend of IBM has a limited annual growth rate of 0.83%.
Dividend Growth(5Y)0.83%
Div Incr Years6
Div Non Decr Years6
IBM.DE Yearly Dividends per shareIBM.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

112.79% of the earnings are spent on dividend by IBM. This is not a sustainable payout ratio.
The dividend of IBM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP112.79%
EPS Next 2Y6.4%
EPS Next 3Y6.27%
IBM.DE Yearly Income VS Free CF VS DividendIBM.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
IBM.DE Dividend Payout.IBM.DE Dividend Payout, showing the Payout Ratio.IBM.DE Dividend Payout.PayoutRetained Earnings

INTL BUSINESS MACHINES CORP

FRA:IBM (5/28/2025, 5:24:57 PM)

231.3

+0.2 (+0.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners64.25%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap214.97B
Analysts72.59
Price Target224.5 (-2.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Yearly Dividend5.91
Dividend Growth(5Y)0.83%
DP112.79%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.28%
Min EPS beat(2)3.59%
Max EPS beat(2)12.97%
EPS beat(4)4
Avg EPS beat(4)7.09%
Min EPS beat(4)2.27%
Max EPS beat(4)12.97%
EPS beat(8)8
Avg EPS beat(8)5.47%
EPS beat(12)11
Avg EPS beat(12)4.29%
EPS beat(16)14
Avg EPS beat(16)3.31%
Revenue beat(2)1
Avg Revenue beat(2)-0.46%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)0.01%
Revenue beat(4)1
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-0.89%
Revenue beat(12)4
Avg Revenue beat(12)-0.27%
Revenue beat(16)6
Avg Revenue beat(16)-2.96%
PT rev (1m)-5.69%
PT rev (3m)6.43%
EPS NQ rev (1m)1.29%
EPS NQ rev (3m)1.07%
EPS NY rev (1m)2.11%
EPS NY rev (3m)1.93%
Revenue NQ rev (1m)2.29%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)1.56%
Revenue NY rev (3m)1.72%
Valuation
Industry RankSector Rank
PE 25.61
Fwd PE 22.46
P/S 3.89
P/FCF 19.53
P/OCF 17.89
P/B 9.08
P/tB N/A
EV/EBITDA 20.14
EPS(TTM)9.03
EY3.9%
EPS(NY)10.3
Fwd EY4.45%
FCF(TTM)11.84
FCFY5.12%
OCF(TTM)12.93
OCFY5.59%
SpS59.53
BVpS25.47
TBVpS-48.87
PEG (NY)3.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.76%
ROE 20.36%
ROCE 8.46%
ROIC 7.22%
ROICexc 8.58%
ROICexgc 54.54%
OM 14.89%
PM (TTM) 8.71%
GM 57.04%
FCFM 19.89%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
ROICexc(3y)8.29%
ROICexc(5y)7.07%
ROICexgc(3y)40.75%
ROICexgc(5y)31.79%
ROCE(3y)8.5%
ROCE(5y)7.33%
ROICexcg growth 3Y26.58%
ROICexcg growth 5Y17.04%
ROICexc growth 3Y17.55%
ROICexc growth 5Y7.25%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 5.06
Debt/EBITDA 4.01
Cap/Depr 24.38%
Cap/Sales 1.83%
Interest Coverage 250
Cash Conversion 97.03%
Profit Quality 228.33%
Current Ratio 1.01
Quick Ratio 0.97
Altman-Z 3.33
F-Score5
WACC9.67%
ROIC/WACC0.75
Cap/Depr(3y)35.46%
Cap/Depr(5y)39.55%
Cap/Sales(3y)2.66%
Cap/Sales(5y)3.73%
Profit Quality(3y)294.17%
Profit Quality(5y)264.98%
High Growth Momentum
Growth
EPS 1Y (TTM)3.22%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%-4.76%
EPS Next Y6.87%
EPS Next 2Y6.4%
EPS Next 3Y6.27%
EPS Next 5Y7.16%
Revenue 1Y (TTM)1.23%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%0.55%
Revenue Next Year5.33%
Revenue Next 2Y4.83%
Revenue Next 3Y4.61%
Revenue Next 5Y4.68%
EBIT growth 1Y5.13%
EBIT growth 3Y16.81%
EBIT growth 5Y3.49%
EBIT Next Year59.42%
EBIT Next 3Y21.07%
EBIT Next 5Y10.85%
FCF growth 1Y39.31%
FCF growth 3Y7.1%
FCF growth 5Y0.76%
OCF growth 1Y24.5%
OCF growth 3Y1.67%
OCF growth 5Y-1.86%